Partnership to accelerate growth and drive new market entry, with a focus on Asia

We are really excited to license these premium brands from EMMAC. The nutraceutical products will serve as an entry point for Yooma into this new product category”

— Ron Wardle, CEO of Yooma

TORONTO, ONTARIO, CANADA, January 20, 2021 /EINPresswire.com/ — EMMAC Life Sciences Group (“EMMAC” or the “Group”), Europe’s largest independent cannabis company, and Yooma Corp. (“Yooma”), one of Asia’s leading CBD and wellness social commerce companies, today announced they have entered into a licensing agreement whereby Yooma will license EMMAC’s wellness brands, including Blossom, MYO, Hello Joya and What the Hemp (the “EMMAC Brands”). Under the terms of the Agreement, Yooma will have exclusive rights for the distribution and sale of the EMMAC Brands in China, Japan, Taiwan, and Australia as well as non-exclusive distribution rights in certain other global markets.

Blossom produces premium quality CBD skincare and wellness products, currently sold through various on-line channels in Europe and select retailers in the United Kingdom. MYO Plant Nutrition combines high-quality plant ingredients with cannabinoids and other active ingredients to produce performance-enhancing nutritional supplements in 100% compostable recyclable packaging. What The Hemp and Hello Joya are both plant-based hemp snack brands currently sold through select retail partners in France with What The Hemp also being available in certain stores in the UK.

Yooma intends to integrate the EMMAC Brands into its existing sales channels in Asia, including cross-border eCommerce in China on various Alibaba platforms.

Ron Wardle, CEO of Yooma, said: “We are really excited to license these premium brands from EMMAC. The nutraceutical products will serve as an entry point for Yooma into this new product category, and exclusive licensing of Blossom will facilitate the opening of a TMall flagship store. Furthermore, we expect that the licensing model will result in improved unit economics for Yooma.”

Antonio Costanzo, CEO of EMMAC, said: “We are very pleased to be partnering with Yooma. Their expertise in CBD Lifestyle brands, as well as their established footprint in Asia, will bring immediate scale and expertise to our exciting portfolio of wellness brands. We look forward to seeing increased momentum in product sales in new and emerging markets, as well as building momentum in Europe.”

About EMMAC Life Sciences Group
EMMAC Life Sciences Group is Europe’s largest independent cannabis company, bringing together pioneering science and research with cutting-edge cultivation, extraction, and production. With a unique supply and distribution network throughout Europe, EMMAC’s vision is to bring the life-enhancing potential of cannabis to the people who need it. For more information about EMMAC, please visit https://www.emmac.com/.

For general enquiries please contact info@emmac.com or visit www.emmac.com

Media enquiries:
Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz Tel: +44 (0) 20 7466 5000
emmac@buchanan.uk.com www.buchanan.uk.com


Through its wholly-owned subsidiary, EDA and subsidiaries based in China, Japan and the United States, Yooma intends to leverage the success and experience of its senior management to build Yooma’s business into one of Asia’s leading cannabinoid (CBD) and wellness products social commerce companies through the distribution and sale of CBD beauty and skincare and other wellness products via a strategically curated network of sales channels. Yooma has assembled a strong international team of multicultural industry professionals with extensive experience in digital marketing, eCommerce and social media in the pan-Asian region with particular depth in the Chinese eCommerce market. For more information, please visit www.yooma.ca

Media Contact:
Yooma Corp.
Ron Wardle
Email: rwardle@yooma.ca


Notice regarding Forward Looking Statements
All information included in this press release, including any information as to the future financial or operating performance and other statements of Yooma that express management’s expectations or estimates of future performance, other than statements of historical fact, constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management’s current expectations and plans relating to the future. Wherever possible, words such as “plans”, “expects”, “scheduled”, “trends”, “forecasts”, “future”, “indications”, “potential”, “estimates”, “predicts”, “anticipate”, “to establish”, “believe”, “intend”, “ability to”, or statements that certain actions, events or results “may”, “should”, “could”, “would”, “might”, “will”, or are "likely" to be taken, occur or be achieved, or the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, all disclosure regarding future results of operations, economic conditions and anticipated courses of action, including any intended uses of the EMMAC Brands in Yooma’s operations, Yooma’s expansion into new product categories, any intention of Yooma to open a Tmall flagship store and any improvements in Yooma’s unit economics.

There are many risks and uncertainties that may affect forward-looking statements including, among others, regulatory risk in each jurisdiction in which Yooma does or intends to operate, the uncertainties, effects of and responses to the COVID-19 pandemic, reliance on licenses, competition, dependence on senior management and key personnel, general business risk and liability, regulation of the CBD industry, changes in laws, regulations and guidelines, compliance with laws, limited operating history, unfavourable publicity or consumer perception, product liability, risks related to intellectual property, product recalls, difficulties with forecasts, management of growth and litigation, many of which are beyond the control of Yooma. Although the forward-looking statements contained herein reflect management's current beliefs and reasonable assumptions based upon information available to management as of the date hereof, Yooma cannot be certain that actual results will be consistent with such forward-looking information. Yooma cautions you not to place undue reliance upon any such forward-looking statements. Yooma disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of Yooma.

Ron Wardle
Yooma Corp
email us here

Source: EIN Presswire